FDA Clears DyAnsys Neurostimulation Device Primary Relief to Treat C-Section Pain

PALO ALTO, Calif., July 28, 2022 /PRNewswire/ -- DyAnsys, Inc., has announced that Primary Relief, a percutaneous electrical neurostimulation device, has been clearedto treat pain following a Caesarean-section (C-section). Primary Relief, a PENS device, is a significant alternative to...

Click to view original post